Prawo i regulacje · 12/08/2016

DEA Expands Marijuana Research Registration Policy

The U.S. Drug Enforcement Administration (DEA) is introducing a new policy to expand the number of entities registered under the Controlled Substances Act (CSA) to manufacture marijuana for legitimate research purposes in the United States. This policy aims to facilitate research involving marijuana and its chemical constituents, while adhering to the CSA and international drug control treaty obligations.